Ireland
--:--IST
Recruiting Observational

Feasibility Study of a Transition Pathway at Discharge From Full Hospitalization in Oncology

NCT07256444 · tracked via the Priya Life Science France tracker
Phase
Observational
Started
2026-06-02
Last updated
2026-06-09

Condition(s) studied

Cancer

Investigational drug(s) / intervention(s)

OncoCare transition program

OncoCare transition program: Interview with the coordinating nurse who reviews the patient's prescriptions and appointments, installs the electronic patient-reported outcome (ePRO) application on the patient's smartphone and explains collection of any symptoms. ePRO symptom monitoring by the patient on D2, D7 and D15 after discharge. The coordinating nurse phones the patient on D7 to review the symptoms reported, assess compliance with treatment and provide support. In the event of grade ≥ 2 symptoms, the nurse contacts the patient for further information and informs the referring oncologist, who decides on the course of treatment.

Study summary

Patient reported outcomes (PRO) measure the health status directly reported by the patients, without external interpretation, generally collected using self-questionnaires, including online tools (ePRO). This approach is useful in early detection of signs of relapse, with reduced anxiety, improved quality of life and survival, and reduced readmissions to emergency departments in patients with advanced cancer. In the current context where hospitalization is increasingly short, the transition from hospital to home is a critical moment that poses a significant safety challenge Patient follow-up strategies help patients return home, particularly in surgery, with telephone calls from a nurse the day after or several days after discharge. In oncology, telephone calls from the pharmacist 3 days after discharge from hospital helped to identify undesirable effects of treatments. In general medicine, these calls have led to improved patient satisfaction, reduced use of emergency departments and the resolution of drug-related problems, but are costly. The introduction of post-hospitalization ePRO monitoring in oncology could ensure effective follow-up while keeping costs under control. A coordinating nurse could manage this process and play a crucial role in accompanying patients when they return home.

The study authors aimed to evaluate the feasibility of a transitional nurse consultation and ePRO follow-up on discharge from full hospitalization in oncology in this population of frail and elderly patients.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * The patient must have given their free and informed consent and signed the consent form * The patient must be a member or beneficiary of a health insurance plan * Adult patient hospitalized in an oncology unit for at least 48 hours. * Patient capable of using a connected device, in possession of a smartphone or tablet, and with an internet connection at home. * Patient discharged from hospital to go home. Exclusion Criteria: * The patient is in a period of exclusion determined by a previous study * The subject refuses to sign the consent * It is impossible to give the subject informed information * The patient is under safeguard of justice or state guardianship * Patient considered to be at the end of life. * Patient unable to read and understand French * Patient discharged from hospitalization to a home care facility * Patient having been hospitalized in a full-time inpatient setting for a scheduled procedure (chemotherapy or interventional procedure) * Pregnant, parturient, or breastfeeding

Primary outcome measure(s)

  • Compliance with ePRO monitoring — Day 2
    Percentage of patients who responded to all questionnaires
  • Compliance with the telephone call at day 7 — Day 7
    Percentage of patients successfully contacted at day 7
  • Patient satisfaction with the care pathway — Day 15
    Question: "Are you satisfied with your care pathway?" (Yes/no)

Trial sites (1)

FacilityCityRegionStatus
Centre Hospitalier de Nimes Nîmes France Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07256444 on ClinicalTrials.gov ↗ ← All trials in France